Hemo Organic Peer Comparison

Snapshot Summary

Hemo Organic Ltd. is significantly underperforming compared to its peers in terms of growth, profitability, and valuation metrics. Companies like Sun Pharmaceutical and Dr. Reddy's Laboratories stand out as sector leaders with strong financials, indicating a stark contrast to Hemo's zero growth and profitability metrics.

• Hemo Organic Ltd. has zero revenue growth and profitability metrics, making it a clear underperformer.
• Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability and growth metrics, showing strong EPS and ROE figures.
• Cipla Ltd. stands out as a value pick with low PE and PEG ratios amid solid profitability.

• Sun Pharmaceutical Industries Ltd.: Highest revenue growth of 8.42% YoY and strong EPS of 45.55, with solid ROE of 16.13%.
• Dr. Reddy's Laboratories Ltd.: Strong profitability with a PE of 15.5, ROE of 21.76%, and high revenue growth of 16.54% YoY.
• Cipla Ltd.: Attractive valuation with a PE of 23.73 and PEG of 0.35, alongside solid revenue growth and profitability.

Stocks	CMP	Market Cap	P/E	ROCE (%)	Debt/Equity
Hemo Organic Ltd.	₹9.80	₹3.40Cr	20.84	-	-
SUNPHARMA	₹1,563.35	₹3,75,099.26Cr	87.59	17.60%	0.04
DIVISLAB	₹6,091.05	₹1,61,698.50Cr	73.20	16.46%	-
CIPLA	₹1,587.60	₹1,28,217.27Cr	23.73	22.77%	0.01
TORNTPHARM	₹3,581.55	₹1,21,215.77Cr	61.53	24.28%	0.57
DRREDDY	₹1,280.30	₹1,06,835.27Cr	15.50	26.86%	0.07
MANKIND	₹2,518.95	₹1,03,926.59Cr	55.18	28.38%	0.02

Explore

Watchlists

Command Palette

Hemo Organic Peer Comparison

Snapshot Summary